Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis

British Journal of Surgery

Volumn 91, Issue 8, 2004, Pages 1027-1033

  Johnson, C D ^a   Lempinen, M ^c   Imrie, C W ^b   Puolakkainen, P ^c   Kemppainen, E ^c   Carter, R ^b   McKay, C ^d  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Southampton General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TRYPSINOGEN ACTIVATION PEPTIDE; BIOLOGICAL MARKER; OLIGOPEPTIDE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TIME; ACUTE DISEASE; APACHE; EVALUATION; MIDDLE AGED; PANCREATITIS; PREDICTION AND FORECASTING; PROGNOSIS; ROC CURVE; URINE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; APACHE; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE;

EID: 4043180544     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4612     Document Type: Article

References (20)

1. Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4-8.
2. Schmidt J, Fernandez del Castillo C, Rattner DW, Lewandrowski K, Compton CC, Warshaw A. Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates. Gastroenterology 1992; 103: 1009-1016.
3. Tenner S, Fernandez del Castillo C, Warshaw A, Steinberg W, Henman-Taylor J, Vahenzuela JE et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997; 21: 105-110.
4. Neoptolemos JP, Kemppainnen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-1960.
5. Hofbauer B, Saluja AK, Lerch MM, Bhagat M, Lee HS, Frossard JL et al. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol 1998; 275: G352-G362.
6. Heath DI, Cruickshank A, Gudgeon AM, Jehanli A, Shenkin A, Irnrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-45.
7. Messmann H, Vogt W, Holstege A, Lock G, Heinisch A, von Furstenberg A et al. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997; 40: 80-85.
8. Heath DI, Cruickshank A, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995; 10: 347-353.
9. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177-181.
10. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut 1984; 25: 1340-1346.
11. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139: 69-81.
12. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; ii: 201-205.
13. Brown A, Baillargeon JD, Hughes MD, Banks PA. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatology 2002; 2: 104-107.
14. Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48: 62-69.
15. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590.
16. Buter A, Imrie CW, Carter CR, Evans S, McKay CJ. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002; 89: 298-302.
17. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23: 1638-1652.
18. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271: 703-707.
19. United Kingdom guidelines for the management of acute pancreatitis. British Society of Gastroenterology. Gut 1998; 42(Suppl 2): S1-S13.
20. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999; 25: 195-210.